Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.
Sood
Anil K
AK
Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA. asood@mdanderson.org
Coleman
Robert L
RL
Wolf
Judith K
JK
Gershenson
David M
DM
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D018925:Chemokines / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control* / Q000601:surgery; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic
D000970:Antineoplastic Agents; D018925:Chemokines